Results
Filtros
Anvisa may vote on rules for national cultivation and control of cannabis this Wednesday (13)
Change may authorize cultivation by companies under strict control, with a limit of 0.3% THC; measure complies with a decision from the Superior Court of Justice (STJ) related to cultivation regulation.
Anvisa approves resolutions to regulate cannabis cultivation in Brazil
Agency defines modular strategy for cannabis cultivation, establishing distinct rules for patient associations, research, and industry
Associations may have more space in the debate on the regulation of cannabis cultivation in Brazil
Entrepreneur Fabrício Penafiel considers the inclusion of practical experience of producers in the proposal, with a deadline set for September 30th, a historic opportunity.
Senate may vote on bill in February that regulates the medicinal use of cannabis
Proposal creates a legal framework for production, importation, and self-cultivation; the report included strict security requirements for the medicinal use of cannabis
“Extended deadline creates the possibility of presenting a more consistent proposal,” says Anvisa director about regulation of cultivation
Thiago Campos advocates for the extension of the regulation deadline and reinforces the importance of social listening in the process
Suplicy shows 54% improvement in Parkinson's symptoms after treatment with medical cannabis
Case study using THC highlights advances in mobility, quality of life, and sleep
Anvisa proposes strict rules for cannabis cultivation for research purposes in Brazil
New resolution allows planting by universities and pharmaceutical industries, requiring maximum security systems and total traceability of the plant
Government discusses regulation of cannabis and promises interministerial agenda
Minister Guilherme Boulos meets sector to discuss working group and inclusion of associations in new medicinal cannabis legislation
Cannabis cultivation and regulatory review take center stage in the 2026–2027 Regulatory Agenda
Approved document defines 161 priority topics for the next two years, including national cultivation of low-THC cannabis
Anvisa publishes call for scientific evidence on cannabis cultivation
Agency seeks technical input for new regulation on plant cultivation in Brazil
Anvisa and scientific community discuss medicinal cannabis cultivation today (11)
Meeting is part of the agency's actions to build a technical and participatory regulation on the medicinal use of the plant
Translating Medicine to Justice: The Role of the Agronomic Report in Habeas Corpus
Experts explain why the report has become indispensable to prove the therapeutic purpose and ensure the continuity of treatment
Court grants right to patient with ADHD to cultivate cannabis to produce their own medicinal oil
TRF-3 grants safe conduct for importing seeds and cultivating up to 138 cannabis plants, recognizing the right of a patient to produce their own medicinal oil to treat ADHD and temporomandibular joint pain
Regulation of cultivation comes up for discussion at Anvisa after request for extension
10/06/2025The subject is on the agenda of the 6th Public Meeting of the Collegiate Board of Directors (Dicol) of 2025, scheduled for Wednesday (10/08)
Embrapa, The Green Hub, and Instituto Ficus sign agreement to boost research and agribusiness of cannabis in Brazil
08/27/2025Unprecedented partnership aims to combine science, innovation, and regulation to turn hemp into a new frontier of Brazilian agribusiness
Patient with complex clinical condition obtains habeas corpus for cannabis cultivation in Rio
Court authorizes homemade production of Cannabis sativa for medicinal purposes until 2027, based on medical prescription, technical reports, and favorable opinion from the Prosecutor's Office
Proposal to regulate cannabis cultivation is taken off Anvisa's meeting agenda
Decision postpones vote on new rules for cultivating low-THC varieties; new date for analysis not yet defined
From Cultivation to Patient: Behind the Scenes of Safety and Quality of Cannabis-Based Products in Brazil
10/13/2026The safety and efficacy of cannabis-based products depend on an integrated chain involving chemists, biomedicals, pharmacists, and doctors — professionals who ensure, at each stage, the quality, stability, and trust in patient treatment
Medical Cannabis: Understand What It Is, What It's For, and the Rules in Brazil
Discover what medical cannabis is, what it's for, and how this treatment has been advancing in Brazil, with proven benefits and safe medical guidance
Anvisa suspends review of RDC 327 after director's request for further analysis
Rapporteur Rômison Mota advocated for changes impacting imports via RDC 660; new rule prioritizes national products when there is equivalence